Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Braxia Scientific Corp
C.BRAX
Alternate Symbol(s):
BRAXF
Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating...
multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
CSE:BRAX - Post Discussion
Braxia Scientific Corp
> Proposed Settlement in Class Action Lawsuit Against Braxia
New Post
View:
Discussion
List
(1)
•••
KNDlaw
X
View Profile
View Bullboard History
Post by
KNDlaw
on Apr 30, 2022 5:43pm
Proposed Settlement in Class Action Lawsuit Against Braxia
Good day all,
There has been a proposed settlement reached in the class action that was commenced in the Supreme Court of British Columbia against Braxia Scientific Corp. (formerly "Champignon Brands Inc.") and certain other defendants. The action has now been certified for settlement purposes. The proposed settlement is subject to Court approval, and the approval hearing is set for July 15, 2022. More information is available at:
https://knd.law/class-actions/braxia-scientific-corp/
Have a good weekend,
KND Complex Litigation
(31)
•••
Korcan
X
View Profile
View Bullboard History
Comment by
Korcan
on May 02, 2022 12:56am
This post has been removed in accordance with Community Policy
(1)
•••
cautiousguy
X
View Profile
View Bullboard History
Comment by
cautiousguy
on May 02, 2022 1:57am
Newtcon,- too embarrassed to post under his own name- given his miserably misguided two year analysis of Shrm/Apothesisssss/and Braxia has put his hand once again up his ventriloquist dummy's puppet skirt and said the following... "Go FUK yourself." I'm sure he will give himself/or his twin sister will give him a thumbs up because he is so very clever. BTW, Is
...more
(1)
•••
KNDlaw
X
View Profile
View Bullboard History
Comment by
KNDlaw
on May 10, 2022 6:50pm
Good day all, Due to a conflict that arose in the schedule of the Supreme Court of British Columbia, the hearing for approval of the proposed settlement in the class action against Braxia Scientific Corp. has been moved from July 15, 2022 to July 18, 2022. Further information about the proposed settlement is available at: https://knd.law/class-actions/braxia-scientific-corp/ Best, KND
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >